Concepedia

Publication | Open Access

Podocalyxin Is a Marker of Poor Prognosis in Pancreatic Ductal Adenocarcinoma

DOIFull Paper Access

34

Citations

22

References

2015

Year

Kapo Saukkonen, Jaana Hagström, Harri Mustonen, Anne Juuti, Stig Nordling, Christian Fermér, Olle Nilsson, Hanna Seppänen, Caj Haglund
PLoS ONE

Abstract

We found podocalyxin to be an independent factor for poor prognosis in PDAC. To our knowledge, this is the first such report of its prognostic value.

References

YearCitations

Page 1